{"corpus_id":24041837,"paper_sha":"203c35e775582c162b92444700ef8f39d057889f","doi":"10.1046/J.1523-1755.2002.00434.X","arxiv_id":null,"pmid":12081584,"pmcid":null,"mag_id":2045847718,"dblp_id":null,"acl_id":null,"title":"Sevelamer attenuates the progression of coronary and aortic calcification in hemodialysis patients.","year":2002,"publication_date":"2002-07-01","venue":"Kidney International","journal":{"name":"Kidney international","pages":"\n          245-52\n        ","volume":"62 1"},"journal_issn":null,"journal_title":null,"publication_types":["JournalArticle","ClinicalTrial"],"pubmed_pub_types":["Clinical Trial","Journal Article","Randomized Controlled Trial","Research Support, Non-U.S. Gov't"],"s2_fields_of_study":["Medicine"],"reference_count":50,"citation_count":1485,"influential_citation_count":46,"is_open_access":true,"arxiv_categories":null,"arxiv_license":null,"arxiv_journal_ref":null,"mesh_headings":[{"d":"Adult","mj":false,"ui":"D000328"},{"d":"Aged","mj":false,"ui":"D000368"},{"d":"Aortic Diseases","mj":false,"qs":[{"q":"prevention & control","mj":true,"ui":"Q000517"}],"ui":"D001018"},{"d":"Calcinosis","mj":false,"qs":[{"q":"prevention & control","mj":true,"ui":"Q000517"}],"ui":"D002114"},{"d":"Calcium","mj":false,"qs":[{"q":"blood","mj":false,"ui":"Q000097"}],"ui":"D002118"},{"d":"Coronary Disease","mj":false,"qs":[{"q":"prevention & control","mj":true,"ui":"Q000517"}],"ui":"D003327"},{"d":"Epoxy Compounds","mj":false,"qs":[{"q":"adverse effects","mj":false,"ui":"Q000009"},{"q":"therapeutic use","mj":true,"ui":"Q000627"}],"ui":"D004852"},{"d":"Female","mj":false,"ui":"D005260"},{"d":"Humans","mj":false,"ui":"D006801"},{"d":"Male","mj":false,"ui":"D008297"},{"d":"Middle Aged","mj":false,"ui":"D008875"},{"d":"Parathyroid Hormone","mj":false,"qs":[{"q":"blood","mj":false,"ui":"Q000097"}],"ui":"D010281"},{"d":"Polyamines","mj":false,"ui":"D011073"},{"d":"Polyethylenes","mj":false,"qs":[{"q":"adverse effects","mj":false,"ui":"Q000009"},{"q":"therapeutic use","mj":true,"ui":"Q000627"}],"ui":"D011095"},{"d":"Renal Dialysis","mj":false,"qs":[{"q":"adverse effects","mj":true,"ui":"Q000009"}],"ui":"D006435"},{"d":"Sevelamer","mj":false,"ui":"D000069603"}],"chemicals":[{"n":"Epoxy Compounds","ui":"D004852","reg":"0"},{"n":"Parathyroid Hormone","ui":"D010281","reg":"0"},{"n":"Polyamines","ui":"D011073","reg":"0"},{"n":"Polyethylenes","ui":"D011095","reg":"0"},{"n":"Sevelamer","ui":"D000069603","reg":"9YCX42I8IU"},{"n":"Calcium","ui":"D002118","reg":"SY7Q814VUP"}],"comments_corrections":null,"source_flags":5,"s2_open_access_pdf_url":"http://www.kidney-international.org/article/S0085253815485424/pdf","s2_open_access_landing_url":"https://www.semanticscholar.org/paper/203c35e775582c162b92444700ef8f39d057889f","s2_open_access_license":"publisher-specific-oa","s2_open_access_status":"BRONZE","pmc_open_access_pdf_url":null,"pmc_open_access_landing_url":null,"pmc_open_access_license":null,"pmc_open_access_status":null,"unpaywall_open_access_pdf_url":null,"unpaywall_open_access_landing_url":null,"unpaywall_open_access_license":null,"unpaywall_open_access_status":null,"abstract":"BACKGROUND\nCardiovascular disease is frequent and severe in patients with end-stage renal disease. Disorders of mineral metabolism may contribute by promoting cardiovascular calcification.\n\n\nMETHODS\nWe conducted a randomized clinical trial comparing sevelamer, a non-absorbed polymer, with calcium-based phosphate binders in 200 hemodialysis patients. Study outcomes included the targeted concentrations of serum phosphorus, calcium, and intact parathyroid hormone (PTH), and calcification of the coronary arteries and thoracic aorta using a calcification score derived from electron beam tomography.\n\n\nRESULTS\nSevelamer and calcium provided equivalent control of serum phosphorus (end-of-study values 5.1 +/- 1.2 and 5.1 +/- 1.4 mg/dL, respectively, P = 0.33). Serum calcium concentration was significantly higher in the calcium-treated group (P = 0.002), and hypercalcemia was more common (16% vs. 5% with sevelamer, P = 0.04). More subjects in the calcium group had end-of-study intact PTH below the target of 150 to 300 pg/mL (57% vs. 30%, P = 0.001). At study completion, the median absolute calcium score in the coronary arteries and aorta increased significantly in the calcium treated subjects but not in the sevelamer-treated subjects (coronary arteries 36.6 vs. 0, P = 0.03 and aorta 75.1 vs. 0, P = 0.01, respectively). The median percent change in coronary artery (25% vs. 6%, P = 0.02) and aortic (28% vs. 5%, P = 0.02) calcium score also was significantly greater with calcium than with sevelamer.\n\n\nCONCLUSIONS\nCompared with calcium-based phosphate binders, sevelamer is less likely to cause hypercalcemia, low levels of PTH, and progressive coronary and aortic calcification in hemodialysis patients.","claims":[{"public_id":"cl_24da5bf57ef7324c71ee595d4805a9e4","status":"active","text":"Calcium-based phosphate binders produced significantly higher serum calcium concentrations and more frequent hypercalcemia (16% vs. 5% with sevelamer) than sevelamer.","confidence":0.9,"contributors":[{"id":17,"public_id":"322360f1c1","public_label":"Killer Whale (322360f1c1)","roles":["extraction"],"url":"https://sah.borca.ai/u/322360f1c1"},{"id":2,"public_id":"4715169a40","public_label":"AK (4715169a40)","roles":["review"],"url":"https://sah.borca.ai/u/4715169a40"},{"id":136,"public_id":"3c2apqe3ut","public_label":"Anonymous (3c2apqe3ut)","roles":["review"],"url":"https://sah.borca.ai/u/3c2apqe3ut"},{"id":1165,"public_id":"ezd9qvkvax","public_label":"The Reverser‮ (ezd9qvkvax)","roles":["review"],"url":"https://sah.borca.ai/u/ezd9qvkvax"}],"url":"https://sah.borca.ai/claims/cl_24da5bf57ef7324c71ee595d4805a9e4"},{"public_id":"cl_401fc9693acfa4066dc680f4fb5add35","status":"active","text":"Median absolute and percent-change calcium scores in the coronary arteries and thoracic aorta increased significantly in calcium-treated hemodialysis patients but not in sevelamer-treated patients.","confidence":0.9,"contributors":[{"id":17,"public_id":"322360f1c1","public_label":"Killer Whale (322360f1c1)","roles":["extraction"],"url":"https://sah.borca.ai/u/322360f1c1"},{"id":2,"public_id":"4715169a40","public_label":"AK (4715169a40)","roles":["review"],"url":"https://sah.borca.ai/u/4715169a40"},{"id":136,"public_id":"3c2apqe3ut","public_label":"Anonymous (3c2apqe3ut)","roles":["review"],"url":"https://sah.borca.ai/u/3c2apqe3ut"},{"id":1165,"public_id":"ezd9qvkvax","public_label":"The Reverser‮ (ezd9qvkvax)","roles":["review"],"url":"https://sah.borca.ai/u/ezd9qvkvax"}],"url":"https://sah.borca.ai/claims/cl_401fc9693acfa4066dc680f4fb5add35"},{"public_id":"cl_001ae8cf686e80f2197387ab0e653f12","status":"active","text":"More subjects treated with calcium-based phosphate binders had end-of-study intact parathyroid hormone below the target range of 150 to 300 pg/mL compared with sevelamer (57% vs. 30%).","confidence":0.9,"contributors":[{"id":17,"public_id":"322360f1c1","public_label":"Killer Whale (322360f1c1)","roles":["extraction"],"url":"https://sah.borca.ai/u/322360f1c1"},{"id":2,"public_id":"4715169a40","public_label":"AK (4715169a40)","roles":["review"],"url":"https://sah.borca.ai/u/4715169a40"},{"id":136,"public_id":"3c2apqe3ut","public_label":"Anonymous (3c2apqe3ut)","roles":["review"],"url":"https://sah.borca.ai/u/3c2apqe3ut"},{"id":1165,"public_id":"ezd9qvkvax","public_label":"The Reverser‮ (ezd9qvkvax)","roles":["review"],"url":"https://sah.borca.ai/u/ezd9qvkvax"}],"url":"https://sah.borca.ai/claims/cl_001ae8cf686e80f2197387ab0e653f12"},{"public_id":"cl_6d41f2f30f708872904f6ffb991ac315","status":"active","text":"Sevelamer and calcium-based phosphate binders provided equivalent control of serum phosphorus, with end-of-study values of 5.1 mg/dL in both groups.","confidence":0.95,"contributors":[{"id":17,"public_id":"322360f1c1","public_label":"Killer Whale (322360f1c1)","roles":["extraction"],"url":"https://sah.borca.ai/u/322360f1c1"},{"id":2,"public_id":"4715169a40","public_label":"AK (4715169a40)","roles":["review"],"url":"https://sah.borca.ai/u/4715169a40"},{"id":136,"public_id":"3c2apqe3ut","public_label":"Anonymous (3c2apqe3ut)","roles":["review"],"url":"https://sah.borca.ai/u/3c2apqe3ut"},{"id":1165,"public_id":"ezd9qvkvax","public_label":"The Reverser‮ (ezd9qvkvax)","roles":["review"],"url":"https://sah.borca.ai/u/ezd9qvkvax"}],"url":"https://sah.borca.ai/claims/cl_6d41f2f30f708872904f6ffb991ac315"}],"concepts":[{"public_id":"co_25d6d00678c8af71f99fd42cb4648beb","status":"active","name":"serum calcium","description":"The blood concentration of calcium, monitored as a mineral metabolism outcome in the trial.","types":["clinical measurement"],"aliases":[],"contributors":[{"id":17,"public_id":"322360f1c1","public_label":"Killer Whale (322360f1c1)","roles":["extraction"],"url":"https://sah.borca.ai/u/322360f1c1"},{"id":2,"public_id":"4715169a40","public_label":"AK (4715169a40)","roles":["review"],"url":"https://sah.borca.ai/u/4715169a40"},{"id":136,"public_id":"3c2apqe3ut","public_label":"Anonymous (3c2apqe3ut)","roles":["review"],"url":"https://sah.borca.ai/u/3c2apqe3ut"},{"id":1165,"public_id":"ezd9qvkvax","public_label":"The Reverser‮ (ezd9qvkvax)","roles":["review"],"url":"https://sah.borca.ai/u/ezd9qvkvax"}],"url":"https://sah.borca.ai/concepts/co_25d6d00678c8af71f99fd42cb4648beb"},{"public_id":"co_3535f0a58f677f50e2e3bb88f7d4902e","status":"active","name":"electron beam tomography","description":"An imaging technique used in this trial to derive calcification scores of the coronary arteries and thoracic aorta.","types":["measurement technique"],"aliases":[],"contributors":[{"id":17,"public_id":"322360f1c1","public_label":"Killer Whale (322360f1c1)","roles":["extraction"],"url":"https://sah.borca.ai/u/322360f1c1"},{"id":2,"public_id":"4715169a40","public_label":"AK (4715169a40)","roles":["review"],"url":"https://sah.borca.ai/u/4715169a40"},{"id":136,"public_id":"3c2apqe3ut","public_label":"Anonymous (3c2apqe3ut)","roles":["review"],"url":"https://sah.borca.ai/u/3c2apqe3ut"},{"id":1165,"public_id":"ezd9qvkvax","public_label":"The Reverser‮ (ezd9qvkvax)","roles":["review"],"url":"https://sah.borca.ai/u/ezd9qvkvax"}],"url":"https://sah.borca.ai/concepts/co_3535f0a58f677f50e2e3bb88f7d4902e"},{"public_id":"co_38da93912d647a0acdf40203ee099ff3","status":"active","name":"coronary artery calcification","description":"Calcium deposition in the coronary arteries, quantified by a calcification score derived from electron beam tomography.","types":["outcome measure","phenomenon"],"aliases":[],"contributors":[{"id":17,"public_id":"322360f1c1","public_label":"Killer Whale (322360f1c1)","roles":["extraction"],"url":"https://sah.borca.ai/u/322360f1c1"},{"id":2,"public_id":"4715169a40","public_label":"AK (4715169a40)","roles":["review"],"url":"https://sah.borca.ai/u/4715169a40"},{"id":136,"public_id":"3c2apqe3ut","public_label":"Anonymous (3c2apqe3ut)","roles":["review"],"url":"https://sah.borca.ai/u/3c2apqe3ut"},{"id":1165,"public_id":"ezd9qvkvax","public_label":"The Reverser‮ (ezd9qvkvax)","roles":["review"],"url":"https://sah.borca.ai/u/ezd9qvkvax"}],"url":"https://sah.borca.ai/concepts/co_38da93912d647a0acdf40203ee099ff3"},{"public_id":"co_4734bbc0e4c326d2d8d867be1f45cbde","status":"active","name":"randomized clinical trial","description":"A controlled study design in which participants are randomly assigned to treatment groups, used here to compare sevelamer with calcium-based binders.","types":["study design"],"aliases":[],"contributors":[{"id":17,"public_id":"322360f1c1","public_label":"Killer Whale (322360f1c1)","roles":["extraction"],"url":"https://sah.borca.ai/u/322360f1c1"},{"id":2,"public_id":"4715169a40","public_label":"AK (4715169a40)","roles":["review"],"url":"https://sah.borca.ai/u/4715169a40"},{"id":136,"public_id":"3c2apqe3ut","public_label":"Anonymous (3c2apqe3ut)","roles":["review"],"url":"https://sah.borca.ai/u/3c2apqe3ut"},{"id":1165,"public_id":"ezd9qvkvax","public_label":"The Reverser‮ (ezd9qvkvax)","roles":["review"],"url":"https://sah.borca.ai/u/ezd9qvkvax"}],"url":"https://sah.borca.ai/concepts/co_4734bbc0e4c326d2d8d867be1f45cbde"},{"public_id":"co_68895bee28a12835e579c20d863e296e","status":"active","name":"aortic calcification","description":"Calcium deposition in the thoracic aorta, quantified by a calcification score derived from electron beam tomography.","types":["outcome measure","phenomenon"],"aliases":["thoracic aorta"],"contributors":[{"id":17,"public_id":"322360f1c1","public_label":"Killer Whale (322360f1c1)","roles":["extraction"],"url":"https://sah.borca.ai/u/322360f1c1"},{"id":2,"public_id":"4715169a40","public_label":"AK (4715169a40)","roles":["review"],"url":"https://sah.borca.ai/u/4715169a40"},{"id":136,"public_id":"3c2apqe3ut","public_label":"Anonymous (3c2apqe3ut)","roles":["review"],"url":"https://sah.borca.ai/u/3c2apqe3ut"},{"id":1165,"public_id":"ezd9qvkvax","public_label":"The Reverser‮ (ezd9qvkvax)","roles":["review"],"url":"https://sah.borca.ai/u/ezd9qvkvax"}],"url":"https://sah.borca.ai/concepts/co_68895bee28a12835e579c20d863e296e"},{"public_id":"co_6cc2204368cbb7ddb0856ceeeafef1cc","status":"active","name":"serum phosphorus","description":"The blood concentration of phosphorus, a mineral metabolism parameter targeted for control by phosphate binders in the trial.","types":["clinical measurement"],"aliases":[],"contributors":[{"id":17,"public_id":"322360f1c1","public_label":"Killer Whale (322360f1c1)","roles":["extraction"],"url":"https://sah.borca.ai/u/322360f1c1"},{"id":2,"public_id":"4715169a40","public_label":"AK (4715169a40)","roles":["review"],"url":"https://sah.borca.ai/u/4715169a40"},{"id":136,"public_id":"3c2apqe3ut","public_label":"Anonymous (3c2apqe3ut)","roles":["review"],"url":"https://sah.borca.ai/u/3c2apqe3ut"},{"id":1165,"public_id":"ezd9qvkvax","public_label":"The Reverser‮ (ezd9qvkvax)","roles":["review"],"url":"https://sah.borca.ai/u/ezd9qvkvax"}],"url":"https://sah.borca.ai/concepts/co_6cc2204368cbb7ddb0856ceeeafef1cc"},{"public_id":"co_9790ebca42ed303b52aba0cbfacf571a","status":"active","name":"hemodialysis patients","description":"Patients with end-stage renal disease treated with hemodialysis, who made up the trial population.","types":["patient population"],"aliases":[],"contributors":[{"id":17,"public_id":"322360f1c1","public_label":"Killer Whale (322360f1c1)","roles":["extraction"],"url":"https://sah.borca.ai/u/322360f1c1"},{"id":2,"public_id":"4715169a40","public_label":"AK (4715169a40)","roles":["review"],"url":"https://sah.borca.ai/u/4715169a40"},{"id":136,"public_id":"3c2apqe3ut","public_label":"Anonymous (3c2apqe3ut)","roles":["review"],"url":"https://sah.borca.ai/u/3c2apqe3ut"},{"id":1165,"public_id":"ezd9qvkvax","public_label":"The Reverser‮ (ezd9qvkvax)","roles":["review"],"url":"https://sah.borca.ai/u/ezd9qvkvax"}],"url":"https://sah.borca.ai/concepts/co_9790ebca42ed303b52aba0cbfacf571a"},{"public_id":"co_a7421c33486a1c0f95b45067dcd66f0b","status":"active","name":"sevelamer","description":"A non-absorbed polymer used as a phosphate-binding drug to lower serum phosphorus in hemodialysis patients.","types":["drug","phosphate binder"],"aliases":["non-absorbed polymer"],"contributors":[{"id":17,"public_id":"322360f1c1","public_label":"Killer Whale (322360f1c1)","roles":["extraction"],"url":"https://sah.borca.ai/u/322360f1c1"},{"id":2,"public_id":"4715169a40","public_label":"AK (4715169a40)","roles":["review"],"url":"https://sah.borca.ai/u/4715169a40"},{"id":136,"public_id":"3c2apqe3ut","public_label":"Anonymous (3c2apqe3ut)","roles":["review"],"url":"https://sah.borca.ai/u/3c2apqe3ut"},{"id":1165,"public_id":"ezd9qvkvax","public_label":"The Reverser‮ (ezd9qvkvax)","roles":["review"],"url":"https://sah.borca.ai/u/ezd9qvkvax"}],"url":"https://sah.borca.ai/concepts/co_a7421c33486a1c0f95b45067dcd66f0b"},{"public_id":"co_ac2b069643378f491f8b7d6a7e0efd8d","status":"active","name":"calcium-based phosphate binders","description":"Phosphate-binding medications containing calcium, used as the comparator treatment to sevelamer in this trial.","types":["drug","phosphate binder"],"aliases":["calcium"],"contributors":[{"id":17,"public_id":"322360f1c1","public_label":"Killer Whale (322360f1c1)","roles":["extraction"],"url":"https://sah.borca.ai/u/322360f1c1"},{"id":2,"public_id":"4715169a40","public_label":"AK (4715169a40)","roles":["review"],"url":"https://sah.borca.ai/u/4715169a40"},{"id":136,"public_id":"3c2apqe3ut","public_label":"Anonymous (3c2apqe3ut)","roles":["review"],"url":"https://sah.borca.ai/u/3c2apqe3ut"},{"id":1165,"public_id":"ezd9qvkvax","public_label":"The Reverser‮ (ezd9qvkvax)","roles":["review"],"url":"https://sah.borca.ai/u/ezd9qvkvax"}],"url":"https://sah.borca.ai/concepts/co_ac2b069643378f491f8b7d6a7e0efd8d"},{"public_id":"co_c0e086c287b5081b9e8c8fb96e41afff","status":"active","name":"hypercalcemia","description":"An abnormally elevated serum calcium concentration, tracked as an adverse outcome of phosphate-binder treatment.","types":["adverse outcome","condition"],"aliases":[],"contributors":[{"id":17,"public_id":"322360f1c1","public_label":"Killer Whale (322360f1c1)","roles":["extraction"],"url":"https://sah.borca.ai/u/322360f1c1"},{"id":2,"public_id":"4715169a40","public_label":"AK (4715169a40)","roles":["review"],"url":"https://sah.borca.ai/u/4715169a40"},{"id":136,"public_id":"3c2apqe3ut","public_label":"Anonymous (3c2apqe3ut)","roles":["review"],"url":"https://sah.borca.ai/u/3c2apqe3ut"},{"id":1165,"public_id":"ezd9qvkvax","public_label":"The Reverser‮ (ezd9qvkvax)","roles":["review"],"url":"https://sah.borca.ai/u/ezd9qvkvax"}],"url":"https://sah.borca.ai/concepts/co_c0e086c287b5081b9e8c8fb96e41afff"},{"public_id":"co_e4c6baf98638ef8fae12753d6e7a5bf4","status":"active","name":"end-stage renal disease","description":"A form of kidney failure requiring renal replacement therapy, associated with high cardiovascular disease risk in this patient population.","types":["condition"],"aliases":[],"contributors":[{"id":17,"public_id":"322360f1c1","public_label":"Killer Whale (322360f1c1)","roles":["extraction"],"url":"https://sah.borca.ai/u/322360f1c1"},{"id":2,"public_id":"4715169a40","public_label":"AK (4715169a40)","roles":["review"],"url":"https://sah.borca.ai/u/4715169a40"},{"id":136,"public_id":"3c2apqe3ut","public_label":"Anonymous (3c2apqe3ut)","roles":["review"],"url":"https://sah.borca.ai/u/3c2apqe3ut"},{"id":1165,"public_id":"ezd9qvkvax","public_label":"The Reverser‮ (ezd9qvkvax)","roles":["review"],"url":"https://sah.borca.ai/u/ezd9qvkvax"}],"url":"https://sah.borca.ai/concepts/co_e4c6baf98638ef8fae12753d6e7a5bf4"},{"public_id":"co_fc25ba281597e85b52f1b8928e480eb7","status":"active","name":"intact parathyroid hormone","description":"A hormone regulating calcium and phosphate metabolism, measured as intact PTH and targeted to 150 to 300 pg/mL in the trial.","types":["biomarker","hormone"],"aliases":["PTH","intact PTH"],"contributors":[{"id":17,"public_id":"322360f1c1","public_label":"Killer Whale (322360f1c1)","roles":["extraction"],"url":"https://sah.borca.ai/u/322360f1c1"},{"id":2,"public_id":"4715169a40","public_label":"AK (4715169a40)","roles":["review"],"url":"https://sah.borca.ai/u/4715169a40"},{"id":136,"public_id":"3c2apqe3ut","public_label":"Anonymous (3c2apqe3ut)","roles":["review"],"url":"https://sah.borca.ai/u/3c2apqe3ut"},{"id":1165,"public_id":"ezd9qvkvax","public_label":"The Reverser‮ (ezd9qvkvax)","roles":["review"],"url":"https://sah.borca.ai/u/ezd9qvkvax"}],"url":"https://sah.borca.ai/concepts/co_fc25ba281597e85b52f1b8928e480eb7"}],"external_ids":{"DOI":"10.1046/J.1523-1755.2002.00434.X","ArXiv":null,"PubMed":12081584,"PubMedCentral":null,"MAG":2045847718,"DBLP":null,"ACL":null},"open_access":{"is_open_access":true,"pdf_url":"http://www.kidney-international.org/article/S0085253815485424/pdf","landing_url":"https://www.semanticscholar.org/paper/203c35e775582c162b92444700ef8f39d057889f","source":"semantic_scholar","pdf_url_source":"semantic_scholar_open_access_pdf","license":"publisher-specific-oa","status":"BRONZE","reason":null},"reference_availability":{"status":"available","references_indexed":true,"full_text_available":false,"full_text_source":null,"count_basis":"semantic_scholar_metadata","extraction_status":"not_applicable","reason":null},"source":{"provider":"episteme2","base_corpus":"semantic_scholar_dump","freshness_mode":"unknown","basis":["semantic_scholar_metadata","postgres_metadata"],"limits":["paper metadata is based on indexed upstream scholarly datasets","claims and concepts are available only for extracted papers","absence of claims or concepts means no extracted graph data is available in this response"],"status":"available","degraded":false,"degraded_reasons":[],"diagnostics":{"status":"available","degraded":false,"degraded_reasons":[],"metadata_status":"available","graph_status":"available","abstract_status":"available"},"source_flags":5},"paper_id":632128,"paper_uid":"cb41a62e-a795-4833-a2a8-e504cb154dfe","canonical_identity":{"paper_id":632128,"paper_uid":"cb41a62e-a795-4833-a2a8-e504cb154dfe","identity_status":"available","lookup_basis":"semantic_scholar_external_id","compatibility_path":"corpus_id"},"url":"https://sah.borca.ai/papers/24041837"}